Harvard Bioscience (HBIO) Operating Income (2016 - 2025)
Historic Operating Income for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $197000.0.
- Harvard Bioscience's Operating Income rose 11051.23% to $197000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.3 million, marking a year-over-year decrease of 74644.78%. This contributed to the annual value of -$6.2 million for FY2024, which is 42793.03% down from last year.
- According to the latest figures from Q3 2025, Harvard Bioscience's Operating Income is $197000.0, which was up 11051.23% from -$819000.0 recorded in Q2 2025.
- Harvard Bioscience's Operating Income's 5-year high stood at $4.0 million during Q2 2022, with a 5-year trough of -$49.7 million in Q1 2025.
- In the last 5 years, Harvard Bioscience's Operating Income had a median value of -$239000.0 in 2021 and averaged -$3.1 million.
- Examining YoY changes over the last 5 years, Harvard Bioscience's Operating Income showed a top increase of 679310.34% in 2022 and a maximum decrease of 270836.82% in 2022.
- Over the past 5 years, Harvard Bioscience's Operating Income (Quarter) stood at $1.7 million in 2021, then crashed by 126.9% to -$457000.0 in 2022, then surged by 161.71% to $282000.0 in 2023, then crashed by 96.1% to $11000.0 in 2024, then soared by 1690.91% to $197000.0 in 2025.
- Its Operating Income was $197000.0 in Q3 2025, compared to -$819000.0 in Q2 2025 and -$49.7 million in Q1 2025.